glp-1 gip vs tirzepatide Reta — what’s actually different?, Tirzepatide hits and receptors., Reta hits GLP-1, GIP, and glucagon., That added glucagon activity is why you’re seeing more aggressive fat glp-1 tirzepatide compounded glp-1 vs

Although patients at risk for diabetes (ie, prediabetes, defined as a hemoglobin A1C 5.7% to 6.4% or a fasting blood glucose level 100 to 125 mg/dL) were included in FDA registration trials of Saxenda or Wegovy, prediabetes is not an FDA indication for any GLP-1 agonist

In a 12-month retrospective study of 339 Second Nature members published in JMIR Formative Research, participants on tirzepatide lost an average of 22.1% of their body weight, and those on semaglutide lost 17.1% 5

M., Boriack, R

pbs.org/newshour/health/doctors-warn-some-popular-weight-loss-drugs-may-raise-risk-of-complications-under-anesthesia Blum D